FIELD: biotechnology; medicine.
SUBSTANCE: invention represents agents and methods for treating interleukin 18 (IL-18) associated diseases and disorders. In particular, the invention describes antibodies which have specificity with respect to free IL-18 and IL-18-binding protein (IL-18BP), intended for use in said methods of treating and diagnosing symptoms.
EFFECT: what is presented is using IL-18-binding protein (IL-18BP) in inflammatory diseases.
11 cl, 16 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IL-18-BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES | 2016 |
|
RU2755691C2 |
| IL-18 BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN TREATING INFLAMMATORY DISEASES | 2016 |
|
RU2810206C1 |
| ANTI-IL-5 ANTIBODIES | 2017 |
|
RU2758008C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| ANTIBODIES TO IL-6 AND THEIR FUSIONS AND CONJUGATES | 2019 |
|
RU2810777C2 |
| ANTI-PD-L1 AND IL-2 CYTOKINES | 2017 |
|
RU2769282C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF IL-8-RELATED DISEASES | 2017 |
|
RU2766112C2 |
| ANTIBODIES DIRECTED AGAINST THE INTERLEUKIN 36 (IL-36R) RECEPTOR | 2016 |
|
RU2745898C2 |
| IL-12 COMPOSITIONS AIMED AT EDB | 2019 |
|
RU2758143C1 |
